Klozapina (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Klozapina" in Polish language version.

refsWebsite
Global rank Polish rank
2nd place
6th place
4th place
7th place
924th place
75th place
4,294th place
205th place

doi.org

dx.doi.org

  • M. Naheed, B. Green, Focus on clozapine, „Current Medical Research and Opinion”, 17 (3), 2001, s. 223–229, DOI10.1185/0300799039117069, PMID11900316 (ang.).
  • Ying Wu i inni, Evidence that clozapine directly interacts on the GABAB receptor, „NeuroReport”, 22 (13), 2011, s. 637–641, DOI10.1097/WNR.0b013e328349739b, PMID21753741 (ang.).
  • Stevin H. Zorn i inni, Clozapine is a potent and selective muscarinic M4 receptor agonist, „European Journal of Pharmacology”, 269 (3), 1994, s. R1–R2, DOI10.1016/0922-4106(94)90047-7, PMID7895765 (ang.).
  • Liana Urichuk i inni, Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions, „Current Drug Metabolism”, 9 (5), 2008, s. 410–418, DOI10.2174/138920008784746373, PMID18537577 (ang.).
  • Kristian Wahlbeck, Maxim V. Cheine, Adib Essali, Clozapine versus typical neuroleptic medication for schizophrenia, „Cochrane Database of Systematic Reviews”, 2, 2000, s. CD000059, DOI10.1002/14651858.CD000059, PMID10796289 (ang.).
  • Herbert Y. Meltzer, Treatment-resistant schizophrenia-the role of clozapine, „Current Medical Research and Opinion”, 14 (1), 1997, s. 1–20, DOI10.1185/03007999709113338, PMID9524789 (ang.).
  • Andreas A.B. Joos, Udo G. Frank, Wolfgang P. Kaschka, Pharmacokinetic interaction of clozapine and rifampicin in a forensic patient with an atypical mycobacterial infection, „Journal of Clinical Psychopharmacology”, 18 (1), 1998, s. 83–85, DOI10.1097/00004714-199802000-00015, PMID9472849 (ang.).
  • C.W. Jackson, J.S. Markowitz, T.D. Brewerton, Delirium associated with clozapine and benzodiazepine combinations, „Annals of Clinical Psychiatry”, 7 (3), 1995, s. 139–141, DOI10.3109/10401239509149041, PMID8646274 (ang.).

drugbank.ca

nih.gov

ncbi.nlm.nih.gov

  • M. Naheed, B. Green, Focus on clozapine, „Current Medical Research and Opinion”, 17 (3), 2001, s. 223–229, DOI10.1185/0300799039117069, PMID11900316 (ang.).
  • Ying Wu i inni, Evidence that clozapine directly interacts on the GABAB receptor, „NeuroReport”, 22 (13), 2011, s. 637–641, DOI10.1097/WNR.0b013e328349739b, PMID21753741 (ang.).
  • Stevin H. Zorn i inni, Clozapine is a potent and selective muscarinic M4 receptor agonist, „European Journal of Pharmacology”, 269 (3), 1994, s. R1–R2, DOI10.1016/0922-4106(94)90047-7, PMID7895765 (ang.).
  • Liana Urichuk i inni, Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions, „Current Drug Metabolism”, 9 (5), 2008, s. 410–418, DOI10.2174/138920008784746373, PMID18537577 (ang.).
  • Kristian Wahlbeck, Maxim V. Cheine, Adib Essali, Clozapine versus typical neuroleptic medication for schizophrenia, „Cochrane Database of Systematic Reviews”, 2, 2000, s. CD000059, DOI10.1002/14651858.CD000059, PMID10796289 (ang.).
  • Herbert Y. Meltzer, Treatment-resistant schizophrenia-the role of clozapine, „Current Medical Research and Opinion”, 14 (1), 1997, s. 1–20, DOI10.1185/03007999709113338, PMID9524789 (ang.).
  • Andreas A.B. Joos, Udo G. Frank, Wolfgang P. Kaschka, Pharmacokinetic interaction of clozapine and rifampicin in a forensic patient with an atypical mycobacterial infection, „Journal of Clinical Psychopharmacology”, 18 (1), 1998, s. 83–85, DOI10.1097/00004714-199802000-00015, PMID9472849 (ang.).
  • C.W. Jackson, J.S. Markowitz, T.D. Brewerton, Delirium associated with clozapine and benzodiazepine combinations, „Annals of Clinical Psychiatry”, 7 (3), 1995, s. 139–141, DOI10.3109/10401239509149041, PMID8646274 (ang.).

sigmaaldrich.com